Richard I. Feldman

3.9k total citations
15 papers, 1.8k citations indexed

About

Richard I. Feldman is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Richard I. Feldman has authored 15 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 3 papers in Oncology. Recurrent topics in Richard I. Feldman's work include PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Mechanisms and Therapy (4 papers) and ATP Synthase and ATPases Research (2 papers). Richard I. Feldman is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (7 papers), Cancer Mechanisms and Therapy (4 papers) and ATP Synthase and ATPases Research (2 papers). Richard I. Feldman collaborates with scholars based in United States, United Kingdom and France. Richard I. Feldman's co-authors include Santo V. Nicosia, Jin Q. Cheng, Mei Sun, Gen Wang, Ma Xiaoling, Qiyuan Liu, Lin Yang, Mark A. Polokoff, Satoshi Kaneko and Jiandong Chen and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Richard I. Feldman

15 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard I. Feldman United States 11 1.3k 524 347 241 209 15 1.8k
Scott T. Eblen United States 24 1.8k 1.4× 445 0.8× 552 1.6× 138 0.6× 218 1.0× 41 2.3k
Hayley M. McDaid United States 20 1.1k 0.8× 916 1.7× 572 1.6× 120 0.5× 233 1.1× 34 1.9k
Aruna Basu United States 19 1.2k 0.9× 690 1.3× 225 0.6× 176 0.7× 234 1.1× 23 1.9k
Petra Janosch Germany 11 1.6k 1.2× 330 0.6× 191 0.6× 378 1.6× 197 0.9× 11 2.0k
Muling Mao United States 14 1.3k 1.0× 501 1.0× 227 0.7× 182 0.8× 222 1.1× 16 1.7k
Carmen Page United States 8 1.9k 1.5× 779 1.5× 183 0.5× 307 1.3× 342 1.6× 8 2.5k
Sam J. Mansour United States 11 1.6k 1.2× 405 0.8× 394 1.1× 128 0.5× 267 1.3× 11 2.0k
Lucia Cicchillitti Italy 23 1.0k 0.8× 370 0.7× 293 0.8× 231 1.0× 463 2.2× 31 1.5k
Daniela Califano Italy 29 1.6k 1.2× 964 1.8× 258 0.7× 229 1.0× 577 2.8× 62 2.6k
Graham C. Fletcher Canada 18 1.4k 1.1× 458 0.9× 684 2.0× 116 0.5× 242 1.2× 30 2.3k

Countries citing papers authored by Richard I. Feldman

Since Specialization
Citations

This map shows the geographic impact of Richard I. Feldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard I. Feldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard I. Feldman more than expected).

Fields of papers citing papers by Richard I. Feldman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard I. Feldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard I. Feldman. The network helps show where Richard I. Feldman may publish in the future.

Co-authorship network of co-authors of Richard I. Feldman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard I. Feldman. A scholar is included among the top collaborators of Richard I. Feldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard I. Feldman. Richard I. Feldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Sim, Derek, et al.. (2021). In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity. Research and Practice in Thrombosis and Haemostasis. 5(5). e12530–e12530. 3 indexed citations
2.
Islam, Imadul, Greg Brown, Judi Bryant, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517. Bioorganic & Medicinal Chemistry Letters. 17(14). 3819–3825. 35 indexed citations
3.
Islam, Imadul, Judi Bryant, Monica J. Kochanny, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 17(14). 3814–3818. 42 indexed citations
4.
Feldman, Richard I., James M. Wu, Mark A. Polokoff, et al.. (2005). Novel Small Molecule Inhibitors of 3-Phosphoinositide-dependent Kinase-1. Journal of Biological Chemistry. 280(20). 19867–19874. 171 indexed citations
5.
Yang, Lin, Han C. Dan, Mei Sun, et al.. (2004). Akt/Protein Kinase B Signaling Inhibitor-2, a Selective Small Molecule Inhibitor of Akt Signaling with Antitumor Activity in Cancer Cells Overexpressing Akt. Cancer Research. 64(13). 4394–4399. 360 indexed citations
6.
Liu, Qiyuan, Satoshi Kaneko, Lin Yang, et al.. (2004). Aurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215. Journal of Biological Chemistry. 279(50). 52175–52182. 257 indexed citations
7.
Yang, Hua, et al.. (2004). Aurora-A Kinase Regulates Telomerase Activity through c-Myc in Human Ovarian and Breast Epithelial Cells. Cancer Research. 64(2). 463–467. 101 indexed citations
8.
Wu, James M., Mary P. Rosser, Anthony R. Howlett, & Richard I. Feldman. (2003). A Cell-Based Adhesion Assay for the Characterization of Integrin α<sub>v</sub>β<sub>3</sub> Antagonists. PubMed. 129. 211–218. 2 indexed citations
9.
Blasko, Eric, Charles B. Glaser, James J. Devlin, et al.. (2002). Mechanistic Studies with Potent and Selective Inducible Nitric-oxide Synthase Dimerization Inhibitors. Journal of Biological Chemistry. 277(1). 295–302. 83 indexed citations
10.
Kuhn, Irene, Marty F. Bartholdi, Hugh Salamon, et al.. (2001). Identification of AKT-regulated genes in inducible MERAkt cells. Physiological Genomics. 7(2). 105–114. 18 indexed citations
11.
Sun, Mei, Gen Wang, June E. Paciga, et al.. (2001). AKT1/PKBα Kinase Is Frequently Elevated in Human Cancers and Its Constitutive Activation Is Required for Oncogenic Transformation in NIH3T3 Cells. American Journal Of Pathology. 159(2). 431–437. 373 indexed citations
12.
Sun, Mei, Richard I. Feldman, Gen Wang, et al.. (2000). Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene. 19(19). 2324–2330. 318 indexed citations
13.
Bartholdi, Marty F., James M. Wu, Haifeng Pu, et al.. (1998). In situ hybridization for gastrin-releasing peptide receptor (GRP receptor) expression in prostatic carcinoma. International Journal of Cancer. 79(1). 82–90. 54 indexed citations
14.
Feldman, Richard I. & David S. Sigman. (1985). Membrane-specific inhibitors of the bovine heart mitochondrial ATPase. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 806(2). 277–282. 2 indexed citations
15.
Feldman, Richard I. & David S. Sigman. (1984). Enzymatic activities in thylakoid membranes, which form medium [32P]NDP and [32P]ATP from 32Pi. European Journal of Biochemistry. 143(3). 583–588. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026